Ex-Ayurveda Director, 14 Others Charged For Forging NEET List In UP

LUCKNOW : The Uttar Pradesh Special Task Force (UPSTF), which is probing into the Ayush admission scam, charged the former director, ayurveda department, counselling in charge and 13 others for forging the NEET merit list.

STF filed a charge sheet in a Lucknow local court on Tuesday against former Ayurveda director SN Singh, counselling in charge Umakant Yadav, former senior assistant director, Ayurveda, Rajesh Singh, and former junior assistant in ayurveda directorate Kailash Chandra Bhaskar. Others who have been chargesheeted include Uptron Powertronics director Kuldeep Verma, AGM, Uptron, Prabodh Singh, directors of private companies Gaurav Gupta, Harshwardhan Tiwari, Saurabh Maurya, Indradev Mishra, Rupesh Ranjan Pandey, Vijay Yadav, along with managers of private firms Alok Trivedi, Dharmendra and Vijay.

All the accused have been charged with sections 420 (cheating), 467 (forgery), 468 (forgery for purpose of cheating), and 471 (fraudulently using documents) of the IPC, and under the Prevention of Corruption Act.

In November 2022, anomalies were flagged by the Union ministry of Ayush in admission of undergraduate students to state’s government and private ayurvedic, unani and homeopathy colleges. The state government handed over the probe to the STF. The STF said it surfaced during the probe that accused SN Singh, in connivance with two other officials and the organizing private firm, Soft Solution Private Limited, reportedly tampered the data they obtained from the directorate which led to admission of undeserving candidates.

 

  • Related Posts

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    New Delhi: The Parliamentary Panel on Health and Family Welfare has recommended various significant regulatory changes in the regulation of medical devices, including decentralisation of approval for all medical devices…

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory